Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Nasser HannaAlan Sandler

Abstract

Etoposide and cisplatin (EP) has been a standard treatment for extensive-disease small-cell lung cancer (SCLC). An earlier phase III trial reported improved survival for patients receiving irinotecan plus cisplatin (IP) versus EP. Our trial was designed to determine if a modified weekly regimen of IP would provide superior survival with less toxicity than EP. The primary objective was to compare overall survival in extensive-disease SCLC patients randomly assigned to receive IP (n = 221) or EP (n = 110). Patients were randomly assigned in 2:1 ratio to cisplatin 30 mg/m2 intravenously (IV) + irinotecan 65 mg/m2 IV on days 1 and 8 every 21 days, or cisplatin 60 mg/m2 IV on day 1, and etoposide 120 mg/m2 IV on days 1 to 3 every 21 days for at least four cycles, until progressive disease, or until intolerable toxicity resulted. Selected grade 3/4 toxicities for IP/EP were: neutropenia (36.2% v 86.5%; P < .01), febrile neutropenia (3.7% v 10.4%; P = .06), anemia (4.8% v 11.5%; P = .02), thrombocytopenia (4.3% v 19.2%; P < .01), vomiting (12.5% v 3.8%; P = .04), and diarrhea (21.3% v 0%; P < .01). There was no significant difference in response rates (48% v 43.6%), median time to progression (4.1 v 4.6 months), or overall survival (m...Continue Reading

References

Oct 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D C IhdeJ C Phares
Apr 29, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C GridelliA R Bianco
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·E BeutlerA Demina
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J von PawelR Gralla
Apr 13, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S KakolyrisV Georgoulias
Jun 12, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D MavroudisUNKNOWN Greek Lung Cancer Cooperative Group
Jan 11, 2002·The New England Journal of Medicine·Kazumasa NodaUNKNOWN Japan Clinical Oncology Group
Dec 19, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stein SundstrømUNKNOWN Norwegian Lung Cancer Study Group
Feb 6, 2003·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Apr 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gregory A MastersUNKNOWN Eastern Cooperative Oncology Group
Mar 3, 2005·Journal of the National Cancer Institute·Hisayuki ShigematsuAdi F Gazdar
Nov 15, 2006·Clinical Oncology : a Journal of the Royal College of Radiologists·C Faivre-Finn, P Lorigan

❮ Previous
Next ❯

Citations

May 8, 2007·Cancer Chemotherapy and Pharmacology·Fumiyoshi OhyanagiMakoto Nishio
Nov 6, 2012·Cancer Chemotherapy and Pharmacology·Fumihiro OshitaKouzo Yamada
Jul 14, 2009·International Journal of Clinical Oncology·Sherif AbdelwahabIbrahim Dwedar
Nov 2, 2011·International Journal of Clinical Oncology·Yuki NakajimaAtsushi Ohtsu
Nov 19, 2011·International Journal of Clinical Oncology·Ryoichi YanoMikio Masada
Dec 25, 2007·Wiener medizinische Wochenschrift·Stefan HoschekWolfgang Hilbe
Nov 10, 2012·Current Treatment Options in Oncology·David R Spigel
Jul 16, 2010·Current Oncology Reports·Estelamari Rodriguez, Rogerio C Lilenbaum
Mar 4, 2010·Medical Oncology·Young Saing KimDong Bok Shin
Sep 15, 2010·Medical Oncology·Derek G PowerNancy E Kemeny
Jan 19, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Angel Artal CortésUNKNOWN SEOM
Apr 20, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Eckart LaackCarsten Bokemeyer
Jan 21, 2009·Nature Clinical Practice. Oncology·Alexander Schmittel, Ulrich Keilholz
Jan 26, 2007·Nature Reviews. Cancer·Jeffrey R JacksonPearl S Huang
Sep 30, 2009·Nature Reviews. Clinical Oncology·Faye M Johnson, Bonnie S Glisson
Feb 2, 2010·Nature Reviews. Clinical Oncology·Janakiraman Subramanian, Ramaswamy Govindan
Jun 22, 2011·Nature Reviews. Clinical Oncology·William N William, Bonnie S Glisson
Jul 31, 2010·Nature Reviews. Drug Discovery·Klaus Strebhardt
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M SørensenUNKNOWN ESMO Guidelines Working Group
Jan 27, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A SchmittelUNKNOWN Arbeitsgemeinschaft Internistische Onkologie Thoracic Oncology Study Group
Feb 15, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Le TreutC Chouaid
Apr 10, 2008·Journal of the National Cancer Institute·Serge LeyvrazUNKNOWN Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation
Feb 1, 2007·Anti-cancer Drugs·Hatem A Azim, Apar Kishor Ganti
Mar 21, 2013·American Journal of Clinical Oncology·Feng-Ming KongUNKNOWN Expert Panel on Radiation Oncology-Lung
Jul 29, 2010·Pancreas·Jonathan R StrosbergUNKNOWN North American Neuroendocrine Tumor Society (NANETS)
May 9, 2009·American Journal of Respiratory and Critical Care Medicine·Sarita Dubey, Charles A Powell
Jun 9, 2009·BMC Urology·Nabil IsmailiAude Flechon
Apr 8, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Primo N LaraDavid R Gandara
Oct 5, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Neal E ReadyEverett E Vokes
Feb 11, 2010·The Oncologist·Thomas E Stinchcombe, Elizabeth M Gore
Feb 24, 2012·Drugs·Raffaele CalifanoPaul Lorigan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.